Glaucoma, a progressive optic neuropathy, is the leading cause of irreversible blindness worldwide. Glaucoma patients are usually initially managed with medications before more invasive ocular surgeries. Laser treatments are the therapies in between medication and surgery. For laser treatments of glaucoma, laser trabeculoplasty and laser transscleral cyclophotocoagulation lower the intraocular pressure by increasing the aqueous outflow and decreasing the aqueous production, respectively.
　　The development of a subthreshold laser technique, the micropulse laser, has been investigated as a potential alternative to traditional glaucoma laser procedures, with an aim to further decrease the risk of side effects without compromising the laser treatment efficacy.
　　The purpose of today’s talk will be to introduce the efficacy and safety of micropulse laser, to report clinical experience of selective laser trabeculoplasty and to further assess argon laser peripheral iridoplasty in the treatment of glaucoma.